Major depression treatment in Germany-descriptive analysis of health insurance fund routine data and assessment of guideline-adherence

Journal of Affective Disorders

Volumn 189, Issue , 2016, Pages 246-253

  Wiegand, Hauke Felix ^a   Sievers, Christoph ^b   Schillinger, Matthias ^c   Godemann, Frank ^c  

^a Epilepsieklinik Tabor   (Germany)

^b BARMER GEK Hauptverwaltung Strategische Analysen Risikomanagement   (Germany)

^c ST JOSEPH KRANKENHAUS   (Germany)

Author keywords

Antidepressants; Guideline adherence; Major depressive disorder; Psychotherapy; Public health

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE;

ADULT; ARTICLE; CHRONICITY; COMORBIDITY; COMPARATIVE STUDY; DEPRESSIVE PSYCHOSIS; FEMALE; GENERAL PRACTITIONER; GERMANY; HEALTH INSURANCE; HUMAN; ICD-10; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL PATIENT; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOTHERAPY; RECURRENT DISEASE; TREATMENT OUTCOME; ADOLESCENT; AGED; DEPRESSIVE DISORDER, MAJOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; FEMALE; GERMANY; GUIDELINE ADHERENCE; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PSYCHOTHERAPY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84943533746     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2015.09.013     Document Type: Article

References (43)

1. L. Andrade, J.J. Caraveo anduaga, P. Berglund, R.V. Bijl, R.D. Graaf, W. Vollebergh, E. Dragomirecka, R. Kohn, M. Keller, and R.C. Kessler The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys Int. J. Methods Psychiatr. Res. 12 2003 3 21
2. American Psychiatric Association, 2010. Practice guideline for the treatment pf patients with major depressive disorder 3rdEd. 1-152.
3. J.R. Asarnow, L.H. Jaycox, N. Duan, A.P. LaBorde, M.M. Rea, P. Murray, M. Anderson, C. Landon, L. Tang, and K.B. Wells Effectiveness of a quality improvement intervention for adolescent depression in primary care clinics: a randomized controlled trial J. Am. Med. Assoc. 293 2005 311 319 10.1001/jama.293.3.311
4. M. Bauer, A. Pfennig, M. Linden, M.N. Smolka, P. Neu, and M. Adli Efficacy of an algorithm-guided treatment compared with treatment as usual J. Clin. Psychopharmacol. 29 2009 327 333 10.1097/JCP.0b013e3181ac4839
5. W.R. Beardslee Prevention of depression in at-risk adolescents J. Am. Med. Assoc. Psychiatry 2013 10.1001/jamapsychiatry.2013.295
6. J.D. Bukh, C. Bock, M. Vinberg, and L.V. Kessing The effect of prolonged duration of untreated depression on antidepressant treatment outcome J. Affect. Disord. 145 2013 42 48 10.1016/j.jad.2012.07.008
7. E. Chesney, G.M. Goodwin, and S. Fazel Risks of all-cause and suicide mortality in mental disorders: a meta-review World Psychiatry 13 2014 153 160
8. B.Ä.K. DGPPN, K.B.V. AWMF, AkdÄ. BPtK, B.Ap.K. DAGSHG, D.G.P.M. DEGAM, and D.G.R.W. DGPs S3-Leitlinie/nationale versorgungsleitlinie unipolare depression DGPPN, ÄZQ, AWMF 2009 1 54
9. A. Duhoux, L. Fournier, L. Gauvin, and P. Roberge 1471-244X-12-142 BMC Psychiatry 12 2012 10.1186/1471-244X-12-142 1-1
10. A.J. Ferrari, A.J. Somerville, A.J. Baxter, R. Norman, S.B. Patten, T. Vos, and H.A. Whiteford Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature Psychol. Med. 43 2012 471 481 10.1017/S0033291712001511
11. W. Gaebel, S. Kowitz, J. Fritze, and J. Zielasek Use of health care services by people with mental illness: secondary data from three statutory health insurers and the German Statutory Pension Insurance Scheme Deutsches Ärzteblatt Int. 110 2013 799 808 10.3238/arztebl.2013.0799
12. W. Gaebel, J. Zielasek, and S. Kowitz Nutzung von Routinedaten für die psychiatrische und psychosomatische Versorgungsforschung Die Psychiatr. 2011 1 11
13. F. Godemann, M. Schillinger, H.F. Wiegand, C. Sievers, and N. Hackel Leitlinienadhärenz in der psychopharmakologischen Behandlung von dementiellen Syndromen-eine Analyse mittels GKV-Routinedaten Neurogeriatrie 11 2 2014 61 68
14. M. Härter, C. Klesse, I. Bermejo, F. Schneider, and M. Berger Unipolar depression: diagnostic and therapeutic recommendations from the current S3/National Clinical Practice Guideline Deutsches Ärzteblatt Int. 107 2010 700 708 10.3238/arztebl.2010.0700
15. G. Heller Measurement of medical outcome quality using administative data in Germany Bundesgesundheitsbl 51 2008 1173 1182 10.1007/s00103-008-0652-0
16. W. Hoffmann, C. Bobrowski, and K. Fendrich Secondary data analysis in the field of epidemiology of health care. Potential and limitations Bundesgesundheitsbl 51 2008 1193 1201 10.1007/s00103-008-0654-y
17. R.B. Jarrett Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders J. Am. Med. Assoc. Psychiatry 70 2013 1152 1160 10.1001/jamapsychiatry.2013.1969
18. R.B. Jarrett, D. Kraft, J. Doyle, B.M. Foster, G.G. Eaves, and P.C. Silver Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial Arch. Gen. Psychiatry 58 2001 381 388
19. W. Katon, P. Robinson, M. Korff, Von, E. Lin, T. Bush, E. Ludman, G. Simon, and E. Walker A multifaceted intervention to improve treatment of depression in primary care Arch. Gen. Psychiatry 53 1996 924
20. K. Kleine-Budde, R. Müller, W. Kawohl, A. Bramesfeld, J. Moock, and W. Rössler The cost of depression-A cost analysis from a large database J. Affect. Disord. 147 2013 137 143 10.1016/j.jad.2012.10.024
21. M. Lader Benzodiazepines revisited-will we ever learn? Addiction 106 2011 2086 2109 10.1111/j.1360-0443.2011.03563.x
22. J.R. Lave, R.G. Frank, H.C. Schulberg, and M.S. Kamlet Cost-effectiveness of treatments for major depression in primary care practice Arch. Gen. Psychiatry 55 1998 645
23. M. Luppa, S. Heinrich, M.C. Angermeyer, H.-H. König, and S.G. Riedel-Heller Cost-of-illness studies of depression J. Affect. Disord. 98 2007 29 43 10.1016/j.jad.2006.07.017
24. C.D. Mathers, and D. Loncar Projections of global mortality and burden of disease from 2002 to 2030 PLoS Med. 3 2006 e442
25. C.A. Melfi, A.J. Chawla, T.W. Croghan, M.P. Hanna, S. Kennedy, and K. Sredl The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression Arch. Gen. Psychiatry 55 1998 1128 1132
26. C. Mitchell, R. Dwyer, T. Hagan, and N. Mathers Impact of the QOF and the NICE guideline in the diagnosis andmanagement of depression: a qualitative study Br. J. Gen. Pract. 61 2011 279 289 10.3399/bjgp11X572472
27. National Institute for Health and Clinical Excellence Depression: the treatment and management of depression in adults (update) Clin. Guidel. 90 2009 1 67
28. S.B. Patten, J.V.A. Williams, D.H. Lavorato, A.G.M. Bulloch, and G. MacQueen Depressive episode characteristics and subsequent recurrence risk J. Affect. Disord. 140 2012 277 284 10.1016/j.jad.2012.02.006
29. S.H. Pedersen, K.B. Stage, A. Bertelsen, P. Grinsted, P. Kragh-Sørensen, and T. Sørensen ICD-10 criteria for depression in general practice J. Affect. Disord. 65 2001 191 194
30. F. Peeters, M. Huibers, J. Roelofs, G. van Breukelen, S.D. Hollon, J.C. Markowitz, J. van Os, and A. Arntz The clinical effectiveness of evidence-based interventions for depression a pragmatic trial in routine practice J. Affect. Disord. 145 2013 349 355 10.1016/j.jad.2012.08.022
31. H. Pincus, A. Page, B. Druss, P. Appelbaum, G. Gottlieb, and M. England Can psychiatry cross the quality chasm? Improving the quality of health care for mental and substance use conditions Am. J. psychiatry 164 2007 712 719
32. J.M. Rubio, M. Olfson, G. Pérez-Fuentes, M. Garcia-Toro, S. Wang, and C. Blanco Effect of first episode axis I disorders on quality of life J. Nerv. Ment. Dis. 202 2014 271 274 10.1097/NMD.0000000000000117
33. A. Rush, M. Trivedi, S. Wisniewski, A. Nierenberg, J. Stewart, D. Warden, G. Niederehe, M. Thase, P. Lavori, and B. Lebowitz Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR∗D report Am. J. Psychiatry 163 2006 1905 1917
34. F. Schneider, S. Kratz, I. Bermejo, R. Menke, C. Mulert, U. Hegerl, M. Berger, W. Gaebel, and M. Härter Insufficient depression treatment in outpatient settings Ger. Med. Sci. 2 2004 Doc01
35. Schulz, H., Barghaan, D., Harfst, T., Koch, U., 2008. Themenheft 41 "Psychotherapeutische Versorgung".
36. M. Smolders, M. Laurant, P. Verhaak, M. Prins, H. van Marwijk, B. Penninx, M. Wensing, and R. Grol Adherence to evidence-based guidelines for depression and anxiety disorders is associated with recording of the diagnosis Gen. Hospital Psychiatry 31 2009 460 469 10.1016/j.genhosppsych.2009.05.011
37. J. Unützer, W. Katon, C.M. Callahan, J.W. Williams Jr., E. Hunkeler, L. Harpole, M. Hoffing, R.D. Penna, Della, P.H. Noël, and E.H. Lin Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial J. Am. Med. Assoc. 288 2002 2836 2845
38. R. van der Lem, N.J.A. van der Wee, T. van Veen, and F.G. Zitman Efficacy versus effectiveness: a direct comparison of the outcome of treatment for mild to moderate depression in randomized controlled trials and daily practice Psychother. Psychosom. 81 2012 226 234 10.1159/000330890
39. J.R. Vittengl, L.A. Clark, T.W. Dunn, and R.B. Jarrett Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy effects J. Consult. Clin. Psychol. 75 2007 475 488 10.1037/0022-006X.75.3.475
40. H.A. Whiteford, L. Degenhardt, J. Rehm, A.J. Baxter, A.J. Ferrari, H.E. Erskine, F.J. Charlson, R.E. Norman, A.D. Flaxman, N. Johns, R. Burstein, C.J.L. Murray, and T. Vos Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 Lancet 1-12 2013 10.1016/S0140-6736(13)61611-6
41. H.U. Wittchen, M. Höfler, and W. Meister Prevalence and recognition of depressive syndromes in German primary care settings: poorly recognized and treated? Int. Clin. Psychopharmacol. 16 2001 121 135
42. H.U. Wittchen, F. Jacobi, J. Rehm, A. Gustavsson, M. Svensson, B. Jönsson, J. Olesen, C. Allgulander, J. Alonso, C. Faravelli, L. Fratiglioni, P. Jennum, R. Lieb, A. Maercker, J. Van Os, M. Preisig, L. Salvador-Carulla, R. Simon, and H.C. Steinhausen The size and burden of mental disorders and other disorders of the brain in Europe 2010 Eur. Neuropsychopharmacol. 21 2011 655 679 10.1016/j.euroneuro.2011.07.018
43. T. Wobrock, S. Weinmann, P. Falkai, and W. Gaebel Quality assurance in psychiatry: quality indicators and guideline implementation Eur. Arch. Psychiatry Clin. Neurosci. 259 2009 219 226 10.1007/s00406-009-0072-7